These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28176651)

  • 1. Lung Cancer Stem Cells: An Epigenetic Perspective.
    Shukla S; Khan S; Sinha S; Meeran SM
    Curr Cancer Drug Targets; 2018; 18(1):16-31. PubMed ID: 28176651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer stem cells and implications for future therapeutics.
    Wang J; Li ZH; White J; Zhang LB
    Cell Biochem Biophys; 2014 Jul; 69(3):389-98. PubMed ID: 24549856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of epigenetic modulation in cancer stem cell fate.
    Deshmukh A; Binju M; Arfuso F; Newsholme P; Dharmarajan A
    Int J Biochem Cell Biol; 2017 Sep; 90():9-16. PubMed ID: 28711634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma.
    Chiou GY; Cherng JY; Hsu HS; Wang ML; Tsai CM; Lu KH; Chien Y; Hung SC; Chen YW; Wong CI; Tseng LM; Huang PI; Yu CC; Hsu WH; Chiou SH
    J Control Release; 2012 Apr; 159(2):240-50. PubMed ID: 22285547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting.
    Heng WS; Gosens R; Kruyt FAE
    Biochem Pharmacol; 2019 Feb; 160():121-133. PubMed ID: 30557553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epigenetics in cancer stem cells].
    Xu LF; Zhang J; Tian ZQ; Wu YZ
    Yi Chuan; 2013 Sep; 35(9):1049-57. PubMed ID: 24400477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance.
    Das PK; Pillai S; Rakib MA; Khanam JA; Gopalan V; Lam AKY; Islam F
    Stem Cell Rev Rep; 2020 Apr; 16(2):397-412. PubMed ID: 31965409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic control of cell signalling in cancer stem cells.
    Joshi G; Basu A
    Int Rev Cell Mol Biol; 2024; 383():67-88. PubMed ID: 38359971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer stem cells: The root of resistance.
    MacDonagh L; Gray SG; Breen E; Cuffe S; Finn SP; O'Byrne KJ; Barr MP
    Cancer Lett; 2016 Mar; 372(2):147-56. PubMed ID: 26797015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer stem cells: tools and targets to fight lung cancer.
    Eramo A; Haas TL; De Maria R
    Oncogene; 2010 Aug; 29(33):4625-35. PubMed ID: 20531299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic targeting of cancer stem cells by polyphenols (cancer stem cells targeting).
    Ghasemi S; Xu S; Nabavi SM; Amirkhani MA; Sureda A; Tejada S; Lorigooini Z
    Phytother Res; 2021 Jul; 35(7):3649-3664. PubMed ID: 33619811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin.
    Yang Y; Fan Y; Qi Y; Liu D; Wu K; Wen F; Zhao S
    Oncol Rep; 2015 Aug; 34(2):929-35. PubMed ID: 26081992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.
    Castilho RM; Squarize CH; Almeida LO
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic alterations involved in cancer stem cell reprogramming.
    Muñoz P; Iliou MS; Esteller M
    Mol Oncol; 2012 Dec; 6(6):620-36. PubMed ID: 23141800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.
    De Francesco EM; Sotgia F; Lisanti MP
    Biochem J; 2018 May; 475(9):1611-1634. PubMed ID: 29743249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.